{"id":"https://openalex.org/W2016009742","doi":"https://doi.org/10.1097/00008571-199610000-00002","title":"Formation of meprobamate from carisoprodol is catalysed byCYP2C19","display_name":"Formation of meprobamate from carisoprodol is catalysed byCYP2C19","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W2016009742","doi":"https://doi.org/10.1097/00008571-199610000-00002","mag":"2016009742","pmid":"https://pubmed.ncbi.nlm.nih.gov/8946470"},"language":"en","primary_location":{"id":"doi:10.1097/00008571-199610000-00002","doi":"https://doi.org/10.1097/00008571-199610000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199610000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"P Dal??n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P Dal??n","raw_affiliation_strings":["Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109324168","display_name":"Gunnar Alv\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"G Alvan","raw_affiliation_strings":["Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084144315","display_name":"Monique Wakelkamp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M Wakelkamp","raw_affiliation_strings":["Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Laboratory Sciences and Technology. Division of Clinical Pharmacology at the Karolinska Institute. Huddinge University Hospital. Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110338520","display_name":"Harald Olsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Olsen","raw_affiliation_strings":["Department of Clinical Pharmacology at Tromso University Hospital. Norway and Department of Psychiatry. Vinderen Hospital. Oslo. Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology at Tromso University Hospital. Norway and Department of Psychiatry. Vinderen Hospital. Oslo. Norway","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3479,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.58557608,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"5","first_page":"387","last_page":"394"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carisoprodol","display_name":"carisoprodol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/meprobamate","display_name":"meprobamate","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9879999756813049},{"id":"https://openalex.org/keywords/debrisoquine-hydroxylation","display_name":"debrisoquine hydroxylation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/drug-metabolism-polymorphisms","display_name":"drug metabolism polymorphisms","score":0.6320000290870667},{"id":"https://openalex.org/keywords/n-dealkylation","display_name":"N-dealkylation","score":0.8790000081062317},{"id":"https://openalex.org/keywords/serum-clearance","display_name":"serum clearance","score":0.6349999904632568},{"id":"https://openalex.org/keywords/muscle-relaxants","display_name":"muscle relaxants","score":0.7459999918937683},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2776838488","wikidata":"https://www.wikidata.org/wiki/Q1175385","display_name":"Mephenytoin","level":5,"score":0.9520081281661987},{"id":"https://openalex.org/C2777937089","wikidata":"https://www.wikidata.org/wiki/Q418351","display_name":"Meprobamate","level":2,"score":0.9226325750350952},{"id":"https://openalex.org/C2777600422","wikidata":"https://www.wikidata.org/wiki/Q3704421","display_name":"Debrisoquine","level":5,"score":0.7772387266159058},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6630527973175049},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5373640656471252},{"id":"https://openalex.org/C2776860028","wikidata":"https://www.wikidata.org/wiki/Q1225289","display_name":"Muscle relaxant","level":2,"score":0.48555800318717957},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.45356816053390503},{"id":"https://openalex.org/C2781109383","wikidata":"https://www.wikidata.org/wiki/Q898497","display_name":"Hydroxylation","level":3,"score":0.4479484260082245},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18581396341323853},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07623371481895447},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.05010581016540527},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002328","descriptor_name":"Carisoprodol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003647","descriptor_name":"Debrisoquin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008620","descriptor_name":"Meprobamate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008658","descriptor_name":"Inactivation, Metabolic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009125","descriptor_name":"Muscle Relaxants, Central","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008571-199610000-00002","doi":"https://doi.org/10.1097/00008571-199610000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199610000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},{"id":"pmid:8946470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8946470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W123082574","https://openalex.org/W2122432309","https://openalex.org/W4210365448","https://openalex.org/W2973033957","https://openalex.org/W2082367924","https://openalex.org/W6990197331","https://openalex.org/W3029864870","https://openalex.org/W2753414103","https://openalex.org/W2073889366","https://openalex.org/W2028003473"],"abstract_inverted_index":{"Carisoprodol":[0],"is":[1,54],"a":[2,164],"muscle":[3],"relaxant":[4],"analgesic,":[5],"which":[6,114],"has":[7],"an":[8,15,174],"active":[9],"metabolite":[10],"i.e.":[11],"meprobamate.":[12,157],"We":[13],"conducted":[14],"open":[16],"three-panel":[17],"single-dose":[18],"administration":[19],"study":[20,121],"with":[21,127,189],"15":[22],"healthy":[23],"volunteers:":[24],"five":[25,30,36],"poor":[26,31,106],"metabolizers":[27,32,38,107,159],"of":[28,33,39,50,61,72,85,99,108,124,136,154,160,177,192],"mephenytoin,":[29],"debrisoquine":[34,147],"and":[35,52,63,76,170,185],"extensive":[37,112],"both":[40],"substrates.":[41],"The":[42,65,83,95],"aim":[43],"was":[44,87,101],"to":[45,90,167],"investigate":[46],"if":[47,187],"the":[48,57,91,116,128,142,152],"elimination":[49,153],"carisoprodol":[51,75,86,100,125,155,169],"meprobamate":[53,79,137],"dependent":[55,180],"on":[56,80],"two":[58,143],"metabolic":[59],"polymorphisms":[60],"mephenytoin":[62,92,109,129,161],"debrisoquine.":[64],"subjects":[66],"were":[67],"given":[68],"single":[69],"oral":[70],"doses":[71,191],"700":[73],"mg":[74,78],"400":[77],"separate":[81],"occasions.":[82],"disposition":[84],"clearly":[88],"correlated":[89],"hydroxylation":[93,130,148],"phenotype.":[94],"mean":[96,133],"serum":[97,134],"clearance":[98,135],"four":[102],"times":[103],"lower":[104,165],"in":[105,111],"than":[110],"metabolizers,":[113],"confirms":[115],"hypothesis":[117],"from":[118],"our":[119],"previous":[120],"that":[122],"N-dealkylation":[123],"cosegregates":[126],"polymorphism.":[131],"However,":[132],"did":[138,149],"not":[139,150],"differ":[140],"between":[141],"groups.":[144],"Also,":[145],"polymorphic":[146],"influence":[151],"or":[156],"Poor":[158],"thus":[162],"have":[163,173],"capacity":[166],"metabolize":[168],"may":[171],"therefore":[172],"increased":[175],"risk":[176],"developing":[178],"concentration":[179],"side-effects":[181],"such":[182],"as":[183],"drowsiness":[184],"hypotension,":[186],"treated":[188],"ordinary":[190],"carisoprodol.":[193]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}